---
figid: PMC5524075__JAH3-6-e005108-g007
figlink: /pmc/articles/PMC5524075/figure/jah32162-fig-0007/
number: Figure 7
caption: 'Interleukin (IL)‐13Rα1 in myocardial metabolism. A, Schematic description
  of the input used to simulate cardiac Il13ra1 −/− metabolism using GSMM. High‐throughput
  data from cardiac tissue of wild‐type (n=4) and Il13ra1 −/− (n=3) mice, and a GSMM
  were used as inputs. The iMAT algorithm integrates the gene‐expression data with
  a genome scale model in order to find a feasible solution space for metabolic flux
  distribution, thus enabling description of posttranscriptional modifications not
  shown by gene expression alone. B, Pathway enrichment analysis over the set of common
  reactions upregulated or downregulated in Il13ra1 −/− cardiac metabolism, computed
  via hypergeometric test and corrected for multiple hypotheses using a false discovery
  rate <0.05. C, Guided by changes in gene‐expression iMAT presents an aberrant energy
  metabolism in Il13ra1‐deficient hearts, consisting of a decrease in glycolysis and
  tricarboxylic acid cycle, with the upregulation of pyruvate. GSMM, genome scale
  metabolic modeling; iMAT, integrative metabolic analysis tool; TCA cycle, tricarboxylic
  acid cycle. Glycolytic metabolites: GLC, glucose; G6P, glucose 6‐phosphate; F6P,
  fructose 6‐phosphate; FDP, fructose 1,6‐bisphosphate; DHAP, dihydroxyacetone phosphate;
  G3P, glyceraldehyde 3‐phosphate; 1,3BPG, 1,3 bisphosphoglycerate; 3PG, 3‐phosphoglycerate;
  2PG, 2‐phosphoglycerate; PEP, phosphoenolpyruvate; PYR, pyruvate. TCA cycle metabolites:
  CIT, citrate; ICIT, isocitrate; AKG, α‐ketoglutarate; SUCCOA, succinyl‐CoA; SUC,
  succinate, FUM, fumarate; MAL, malate; OAA, oxaloacetate. Advance glycosylation
  end products: MTHGXL, methylglyoxal; LACG, lactoylglutathione; LALD, lactaldehyde.'
pmcid: PMC5524075
papertitle: New Role for Interleukin‐13 Receptor α1 in Myocardial Homeostasis and
  Heart Failure.
reftext: Uri Amit, et al. J Am Heart Assoc. 2017 May;6(5):e005108.
pmc_ranked_result_index: '52775'
pathway_score: 0.7508764
filename: JAH3-6-e005108-g007.jpg
figtitle: Interleukin (IL)‐13RA1 in myocardial metabolism
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5524075__JAH3-6-e005108-g007.html
  '@type': Dataset
  description: 'Interleukin (IL)‐13Rα1 in myocardial metabolism. A, Schematic description
    of the input used to simulate cardiac Il13ra1 −/− metabolism using GSMM. High‐throughput
    data from cardiac tissue of wild‐type (n=4) and Il13ra1 −/− (n=3) mice, and a
    GSMM were used as inputs. The iMAT algorithm integrates the gene‐expression data
    with a genome scale model in order to find a feasible solution space for metabolic
    flux distribution, thus enabling description of posttranscriptional modifications
    not shown by gene expression alone. B, Pathway enrichment analysis over the set
    of common reactions upregulated or downregulated in Il13ra1 −/− cardiac metabolism,
    computed via hypergeometric test and corrected for multiple hypotheses using a
    false discovery rate <0.05. C, Guided by changes in gene‐expression iMAT presents
    an aberrant energy metabolism in Il13ra1‐deficient hearts, consisting of a decrease
    in glycolysis and tricarboxylic acid cycle, with the upregulation of pyruvate.
    GSMM, genome scale metabolic modeling; iMAT, integrative metabolic analysis tool;
    TCA cycle, tricarboxylic acid cycle. Glycolytic metabolites: GLC, glucose; G6P,
    glucose 6‐phosphate; F6P, fructose 6‐phosphate; FDP, fructose 1,6‐bisphosphate;
    DHAP, dihydroxyacetone phosphate; G3P, glyceraldehyde 3‐phosphate; 1,3BPG, 1,3
    bisphosphoglycerate; 3PG, 3‐phosphoglycerate; 2PG, 2‐phosphoglycerate; PEP, phosphoenolpyruvate;
    PYR, pyruvate. TCA cycle metabolites: CIT, citrate; ICIT, isocitrate; AKG, α‐ketoglutarate;
    SUCCOA, succinyl‐CoA; SUC, succinate, FUM, fumarate; MAL, malate; OAA, oxaloacetate.
    Advance glycosylation end products: MTHGXL, methylglyoxal; LACG, lactoylglutathione;
    LALD, lactaldehyde.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - PRKG1
  - CS
  - KLK15
  - MAL
  - VCAN
  - PC
  - ENO3
  - TWIST1
  - A4GALT
  - ENO1
  - OTOR
  - FH
  - SDHB
  - ENO2
  - FBXO3
  - ENO4
  - Pyruvate
genes:
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: PGK
  symbol: PGK
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: CS
  symbol: CS
  source: hgnc_symbol
  hgnc_symbol: CS
  entrez: '1431'
- word: ACO
  symbol: ACO
  source: hgnc_alias_symbol
  hgnc_symbol: KLK15
  entrez: '55554'
- word: MAL
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: PGM
  symbol: PG-M
  source: hgnc_alias_symbol
  hgnc_symbol: VCAN
  entrez: '1462'
- word: PC
  symbol: PC
  source: hgnc_symbol
  hgnc_symbol: PC
  entrez: '5091'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO3
  entrez: '2027'
- word: SCS
  symbol: SCS
  source: hgnc_alias_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
- word: PK
  symbol: P(k)
  source: hgnc_alias_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO1
  entrez: '2023'
- word: FDP
  symbol: FDP
  source: hgnc_alias_symbol
  hgnc_symbol: OTOR
  entrez: '56914'
- word: FH
  symbol: FH
  source: hgnc_symbol
  hgnc_symbol: FH
  entrez: '2271'
- word: SDH
  symbol: SDH
  source: hgnc_prev_symbol
  hgnc_symbol: SDHB
  entrez: '6390'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO2
  entrez: '2026'
- word: FBA
  symbol: FBA
  source: hgnc_alias_symbol
  hgnc_symbol: FBXO3
  entrez: '26273'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO4
  entrez: '387712'
chemicals:
- word: Pyruvate
  source: MESH
  identifier: D011773
diseases: []
---
